EU Life Sciences Regulatory Reform 2026: How the Biotech Act, Pharma Rules, Health Data and AI Act Are Reshaping Europe
Europe is reworking the rules governing biotechnology, pharmaceuticals, clinical evidence, health data and artificial intelligence. For life sciences companies, the challenge is no longer just regulatory compliance. It is understanding how these interconnected frameworks will influence innovation, investment, manufacturing and patient access. Europe is entering a consequential period of changeContinue Reading







